Cilostazol (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Cilostazol drug offered from Teva Pharmaceuticals USA Inc. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
| NON-PROPRIETARY NAME: | Cilostazol |
| SUBSTANCE NAME: | CILOSTAZOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-10-24 |
| END MARKETING DATE: | 0000-00-00 |
Cilostazol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cilostazol from Teva Pharmaceuticals USA Inc |
| LABELER NAME: | Teva Pharmaceuticals USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2012-10-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-2064_1cf5c7a5-a0e9-49e4-99e3-e62b76917283 |
| PRODUCT NDC: | 0093-2064 |
| APPLICATION NUMBER: | ANDA077027 |
Other CILOSTAZOL Pharmaceutical Manufacturers / Labelers:
